Collectively, both the declined activation of IGF1–Akt–mTOR pathway induced by impaired IGF-1 signaling/insulin resistance and the decreased activation of FAK-Akt-mTOR pathway caused by reduced FAK phosphorylation play essential roles in regulating skeletal muscle protein synthesis during atrophy conditions. The gene discussed is AKT1; the disease is Insulin resistance.